The efficiency of anti-tumor effect of mefformin for gemcitabine-resistant pancreatic adenocarcinoma

被引：0
|
作者：
Suzuki, Keiichi
Takeuchi, Osamu
Ishii, Yoshiyuki
Osaku, Masayoshi
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-3273
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3273
引用
收藏
页数：4
相关论文
共 50 条
  • [41] ING4 expressing oncolytic vaccinia virus promotes anti-tumor efficiency and synergizes with gemcitabine in pancreatic cancer
    Wu, Yinfang
    Mou, Xiaozhou
    Wang, Shibing
    Liu, Xing-E
    Sun, Xiaodong
    [J]. ONCOTARGET, 2017, 8 (47) : 82728 - 82739
  • [42] Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma
    Zhao, Tiansuo
    Ren, He
    Jia, Li
    Chen, Jing
    Xin, Wen
    Yan, Fan
    Li, Jing
    Wang, Xiuchao
    Gao, Song
    Qian, Dong
    Huang, Chongbiao
    Hao, Jihui
    [J]. ONCOTARGET, 2015, 6 (04) : 2250 - 2262
  • [43] Antitumor Effects of Eribulin Mesylate in Gemcitabine-resistant Pancreatic Cancer Cell Lines
    Takezaki, Yuka
    Namikawa, Tsutomu
    Koyama, Tsuyoshi
    Munekage, Eri
    Munekage, Masaya
    Maeda, Hiromichi
    Kitagawa, Hiroyuki
    Hanazaki, Kazuhiro
    [J]. ANTICANCER RESEARCH, 2016, 36 (11) : 6077 - 6082
  • [44] Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cells
    Che, Pei Pei
    Gregori, Alessandro
    Bergonzini, Cecilia
    Ali, Mahsoem
    Mantini, Giulia
    Schmidt, Thomas
    Finamore, Francesco
    Rodrigues, Stephanie M. Fraga
    Frampton, Adam E.
    McDonnell, Liam A.
    Danen, Erik H.
    Slotman, Ben J.
    Sminia, Peter
    Giovannetti, Elisa
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (05): : 1328 - 1343
  • [45] Adenoviral Therapy Is More Effective in Gemcitabine-resistant Pancreatic Cancer than in Gemcitabine-sensitive Cells
    Yasui, Takaharu
    Ohuchida, Kenoki
    Zhao, Ming
    Cui, Lin
    Onimaru, Manabu
    Egami, Takuya
    Fujita, Hayato
    Ohtsuka, Takao
    Mizumoto, Kazuhiro
    Matsumoto, Kunio
    Tanaka, Masao
    [J]. ANTICANCER RESEARCH, 2011, 31 (04) : 1279 - 1287
  • [46] PEFG salvage therapy in patients with gemcitabine-resistant advanced pancreatic cancer (PC)
    Cereda, S.
    Mazza, E.
    Vitali, G.
    Passoni, P.
    Balzano, G.
    Zerbi, A.
    Staudacher, C.
    Di Carlo, V
    Reni, M.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI50 - XI50
  • [47] In Response to 'Options for the Treatment of Gemcitabine-Resistant Advanced Pancreatic Cancer: Are We There Yet?'
    Gounaris, Ioannis
    Zaki, Kamarul
    Corrie, Pippa
    [J]. JOURNAL OF THE PANCREAS, 2010, 11 (03): : 290 - 290
  • [48] Raltitrexed-eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer
    Reni, M
    Pasetto, L
    Aprile, G
    Cordio, S
    Bonetto, E
    Dell'Oro, S
    Passoni, P
    Piemonti, L
    Fugazza, C
    Luppi, G
    Milandri, C
    Nicoletti, R
    Zerbi, A
    Balzano, G
    Di Carlo, V
    Brandes, AA
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (06) : 785 - 791
  • [49] PEFG salvage therapy inpatients with gemcitabine-resistant advanced pancreatic cancer (PC)
    Cereda, S.
    Mazza, E.
    Passoni, P.
    Nicoletti, R.
    Balzano, G.
    Zerbi, A.
    Staudacher, C.
    di Carlo, V
    Reni, M.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 58 - 59
  • [50] Weekly Epirubicin as Salvage Therapy in Patients with Gemcitabine-Resistant Advanced Pancreatic Cancer
    Cereda, S.
    Rognone, A.
    Mazza, E.
    Fugazza, C.
    Ceraulo, D.
    Villa, E.
    Reni, M.
    [J]. JOURNAL OF CHEMOTHERAPY, 2009, 21 (06) : 698 - 700
12345